From Ancient Egypt to the Science Lab to Your Dinner Plate... Garlic: It's Good for You!
-
$4 Million Gift Helps Create New Center for Inflammatory Bowel Disease at NewYork-Presbyterian/Weill Cornell
-
Adolescent Girl Athletes More Likely to Injure Knees Than Boys
-
Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
-
A Shot in the Arm Could Save Your Child's Life
-
Avon Foundation Breast Imaging Center and Research Lab Open at NewYork-Presbyterian Hospital and Columbia University Medical Center
-
Breathe Easier! Family Guide to Winter Allergies
-
Common Sense and Care: Tips for Holiday Fire Prevention
-
Comprehensive Care for Complex, High-Risk Pregnancies
-
Comprehensive Review Finds Job Stress Does Not Contribute to Chronic High Blood Pressure
-
Contrary to Popular Wisdom, Expressing Anger Is Not Healthy
-
Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
-
DNA Analysis Could Boost Accuracy of Thyroid Tests, NewYork-Presbyterian/Weill Cornell Team Reports
-
Dr. Jack Barchas Receives Institute of Medicine's 2006 Sarnat Award in Mental Health
-
Dr. Joseph Tenenbaum Named New Chief of Medicine Division at NewYork-Presbyterian Hospital/The Allen Pavilion
-
Dr. Laura Forese, Chief Medical Officer, Appointed Chief Operating Officer of NewYork-Presbyterian/Weill Cornell
-
Dr. Richard Polin Receives Education Award from the American Academy of Pediatrics
-
Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment
-
Electrocardiogram Helps Predict Risk for Congestive Heart Failure in Hypertensive Patients
-
Female Smokers Face Double the Risk for Lung Cancer Compared to Male Smokers, NewYork-Presbyterian/Weill Cornell Study Finds
-
For High Blood Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Deadly Atrial Fibrillation
-
Four-Drug Combo Is No Improvement Over Standard Three-Drug Regimen in Suppressing HIV, NewYork-Presbyterian/Weill Cornell-Led Study Finds
-
Fritz Reuter Appointed SVP for Facilities Development and Real Estate at NewYork-Presbyterian
-
From Ancient Egypt to the Science Lab to Your Dinner Plate... Garlic: It's Good for You!
-
Greenberg Prize Awarded to Dr. Isadore Rosenfeld
-
Halloween Horror Movies May Cause Emotional Problems in Young Children
-
How to Avoid Holiday and Winter Weight Gain
-
Improved Treatment for Infants with Misshapen Heads
-
Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
-
IVIG Antibodies Provide Lasting Benefits to Alzheimer's Patients, According to NewYork-Presbyterian/Weill Cornell Study
-
Keeping the Beat: NewYork-Presbyterian Offers Heart Patients New Combination Defibrillator/Pacemakers
-
Landmark Study Reveals That Lung Cancer 10-Year Survival Dramatically Improves With Annual CT Screening and Prompt Treatmen
-
Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
-
Largest U.S. Hepatitis C Trial Provides Insight Into Optimizing Treatment for Patients
-
Latest Findings Presented at Second International Symposium on Pediatric Non-Hodgkin's Lymphoma
-
Learning from 9/11: NewYork-Presbyterian/Weill Cornell Study Reviews Hospital's Disaster Preparedness
-
Lending a Helping Hand: New Device for Stroke Patients Restores Hand Mobility
-
Local Pediatric Patient Heads to Capitol Hill Today in Hopes of Preserving Children's Hospital Funding
-
Merry Stressmas
-
Morgan Stanley Children's Hospital Appoints Emergency Medicine Doctors
-
Most Children with First Complex Febrile Seizures Unlikely to Need Emergency Neuroimaging
-
Multiple Myeloma Oral Therapy REVLIMID Approved by FDA
-
New Alternative to Hip Replacement
-
New Columbia University Division of Geriatric Medicine and Aging to Open at NewYork-Presbyterian/The Allen Pavilion
-
New Procedure Offers Hope to Patients at High Risk for Recurrent Stroke
-
New Radiation Therapy for Prostate Cancer Has Fewer Side Effects
-
New Studies Offer Virtual Reality Therapy for Psychological Victims of Sept. 11
-
NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
-
NewYork-Presbyterian/Columbia Physician has Developed a Potential Nonsurgical Alternative to Mitral Valve Surgery
-
NewYork-Presbyterian/Columbia Sets U.S. Record for Number of Heart Transplants in One Year
-
NewYork-Presbyterian/Columbia Trains Surgeons in New Alternative to Hip Replacement
-
NewYork-Presbyterian/Weill Cornell Names Dr. Nitsana Spigland Chief of Pediatric Surgery
-
NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease
-
NewYork-Presbyterian's Back-To-School Health Checklist
-
NewYork-Presbyterian Launches Awareness Campaign for Interpreter Services Program
-
NewYork-Presbyterian Names Dr. Robert Grant Chief of Plastic and Reconstructive Surgery
-
NewYork-Presbyterian Ranks #1 in New York Magazine's Best Hospitals Survey
-
NewYork-Presbyterian Ranks 6th in Nation in 2006 U.S. News & World Report "Best Hospitals"
-
NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery
-
NewYork-Presbyterian Receives NY State Stroke Center Designation
-
No Tricks – Just Treats!
-
Novel Drug Boosts Platelet Production, Reversing Chronic Immune Thrombocytopenic Purpura (ITP)
-
Nurses Name Physicians of the Year at NewYork-Presbyterian/Weill Cornell
-
NYC's First 3-Way Kidney Transplant
-
NYC Conference on Medical Interpreting and Culturally Competent Health Care
-
NYC First: NewYork-Presbyterian/Columbia Cardiologists Implant Novel Stroke-Prevention Device for Heart Patients with Atrial Fibrillation
-
Parents Happier with Alternative to Liquid Meds for Tonsillectomy
-
Researcher Predicts Paradigm Shift in Heart Disease Treatment
-
Responding to Obesity Epidemic, New Adolescent Bariatric Surgery Center Opens at Morgan Stanley Children's Hospital of NewYork-Presbyterian
-
Review Outlines Risks and Benefits of Body Contouring for Massive Weight Loss After Bariatric Surgery
-
Smokers and Former Smokers Should Be Screened for Lung Cancer, Even If They do not Have Symptoms
-
Surgery Simulators Effective at Training Surgeons
-
Take Me to Chicago!
-
The Facts and Fictions About Flu and Colds
-
The Seventh Issue of Cancer Prevention Has Arrived!
-
Tired of Scratching?
-
Two-Drug Therapy Could Become New Standard of Care for Moderate-to-Severe Male Overactive Bladder
-
U.S. Dept. of Health and Human Services Commends Mental Health Program at NewYork-Presbyterian
-
Winter Exercise Warning
-
Winter Watch for Senior Citizens: 10 Tips for Having a Safe Season
Garlic, recognized for its healing powers in ancient times, is now being rediscovered by medical scientists, who have new evidence of its efficacy against cancer and heart disease. Dr. Richard Rivlin, of NewYork-Presbyterian Hospital/Weill Cornell Medical Center, is guest co-editor of a special March peer-reviewed supplemental issue to The Journal of Nutrition. The issue comprises 35 articles representing the latest research on garlic findings that were first presented at a symposium held last year at Georgetown University.
"Medical texts from China, India, Egypt, Greece and Italy mention medical applications of garlic," says Dr. Rivlin, professor of medicine at Weill Cornell Medical College, attending physician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and director of the Nutrition Center at the Strang Cancer Prevention Laboratory. "Cultures that developed independently came to the same general conclusions, namely, that garlic could be administered to provide strength and to increase work capacity. Hippocrates, considered the Father of Medicine, used garlic as an essential component of one of his therapies."
Dr. Rivlin believes that while much promising research has been made pointing to the disease-preventive and therapeutic effects of garlic, at the present time, it should be considered complementary medicine, not alternative therapy. "The rapid pace of advances in garlic research provides increasing evidence that garlic has significant potential as a complement to established therapies."
New research on the health benefits of garlic, as published in The Journal of Nutrition special issue, include the following:
- Selenium an element found in garlic may be instrumental to garlic's anti-cancer properties. ("Cancer Chemoprevention by Garlic and Garlic-Containing Sulfur and Selenium Compounds," by Drs. K. El-Bayoumy and R. Sinha, Penn. State; Dr. J. Pinto, Cornell-Burke Medical Research Institute; and Dr. R. Rivlin, Weill Cornell Medical College)
- Garlic may slow the progression of coronary artery calcification in patients on statin therapy. ("Aged Garlic Extract Retards Progression of Coronary Artery Disease," by Dr. M. Budoff, Harbor-UCLA Medical Center)
- In addition to its cholesterol-lowering potential, blood-pressure-lowering effects, and antioxidant properties, garlic may help moderate levels of homocysteine, an amino acid that is a marker for coronary artery disease. ("Homocysteine-Lowering Action Is Another Potential Cardiovascular Protective Factor of Aged Garlic Extract," by Drs. Y. Yeh and S. Yeh, Penn. State)
- Garlic may inhibit platelet aggregation a major contributing factor to cardiovascular disease by suppressing calcium mobilization. ("Aged Garlic Extract May Inhibit Aggregation in Human Platelets by Suppressing Calcium Mobilization," by Drs. G. Allison, G. Lowe, and K. Rahman, Liverpool John Moores University, U.K.)
- Garlic may reduce pre-cancerous gastric lesions. ("Factorial Trial Including Garlic Supplements Assesses Effect in Reducing Precancerous Gastric Lesions," by Dr. M. Gail, National Cancer Institute, and Dr. W. You, Beijing Institute of Cancer Research)
- Garlic may suppress progression of precancerous lesions of the large bowel. ("Aged Garlic Extract Has Potential Suppressive Effect on Colorectal Adenomas in Humans," by Drs. S. Tanaka, Hiroshima University, Japan; K. Haruma, Kawasaki Medical School, Japan; M. Yoshihara, Hiroshima University, Japan; G. Kajiyama, Onomichi General Hospital, Japan; K. Kira, Wakunaga Pharmaceutical, Japan; H. Amagase, Wakunaga of America; and K. Chayama, Hiroshima University, Japan)
Studies published in the journal were made possible through a variety of public and private funding sources.